Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
25
ESMC Quote, Financials, Valuation and Earnings
Last price:
$0.16
Seasonality move
:
1.8%
Day range:
$0.15 - $0.16
52-week range:
$0.10 - $0.46
Dividend yield:
0%
P/E ratio:
154.45x
P/S ratio:
0.15x
P/B ratio:
1.13x
Volume:
20K
Avg. volume:
7K
1-year change:
-0.16%
Market cap:
$1.3M
Revenue:
$12M
EPS (TTM):
-$0.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ESMC
Escalon Medical Corp.
|
-- | -- | -- | -- | -- |
|
AXGN
Axogen, Inc.
|
$57.8M | $0.09 | 18.96% | 933.4% | $40.56 |
|
CNMD
CONMED Corp.
|
$310.6M | $0.82 | -2.76% | 322.31% | $44.20 |
|
ELMD
Electromed, Inc.
|
$17.5M | -- | 11.79% | -- | $37.00 |
|
GTHP
Guided Therapeutics, Inc.
|
-- | -- | -- | -- | -- |
|
IRIX
IRIDEX Corp.
|
$11.9M | -$0.07 | 0.12% | -30.56% | $2.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ESMC
Escalon Medical Corp.
|
$0.16 | -- | $1.3M | 154.45x | $0.00 | 0% | 0.15x |
|
AXGN
Axogen, Inc.
|
$34.44 | $40.56 | $1.8B | -- | $0.00 | 0.17% | 7.43x |
|
CNMD
CONMED Corp.
|
$34.79 | $44.20 | $1.1B | 22.48x | $0.20 | 2.35% | 0.77x |
|
ELMD
Electromed, Inc.
|
$23.29 | $37.00 | $189.4M | 22.28x | $0.00 | 0% | 2.91x |
|
GTHP
Guided Therapeutics, Inc.
|
$0.24 | -- | $20.1M | -- | $0.00 | 0% | 24.64x |
|
IRIX
IRIDEX Corp.
|
$0.98 | $2.75 | $17.6M | -- | $0.00 | 0% | 0.32x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ESMC
Escalon Medical Corp.
|
31.63% | 2.970 | 43.39% | 1.03x |
|
AXGN
Axogen, Inc.
|
34.42% | -1.247 | 4.38% | 3.08x |
|
CNMD
CONMED Corp.
|
46.21% | 1.725 | 70.58% | 0.94x |
|
ELMD
Electromed, Inc.
|
-- | 0.121 | -- | 4.40x |
|
GTHP
Guided Therapeutics, Inc.
|
-74.91% | 5.906 | 11.94% | 0.01x |
|
IRIX
IRIDEX Corp.
|
47.94% | 0.152 | 17.71% | 1.18x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ESMC
Escalon Medical Corp.
|
$1.6M | $98.7K | -10.13% | -12.94% | 2.75% | -$517.4K |
|
AXGN
Axogen, Inc.
|
$44.4M | -$9.8M | -8.61% | -13.75% | -16.31% | $1.1M |
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ELMD
Electromed, Inc.
|
$14.8M | $3.6M | 20.33% | 20.35% | 19.16% | $2.4M |
|
GTHP
Guided Therapeutics, Inc.
|
$8K | -$485K | -- | -- | -808.33% | -$279K |
|
IRIX
IRIDEX Corp.
|
$5.5M | -$15K | -45.33% | -119.2% | -0.1% | -$1.2M |
Escalon Medical Corp. vs. Competitors
-
Which has Higher Returns ESMC or AXGN?
Axogen, Inc. has a net margin of 2.72% compared to Escalon Medical Corp.'s net margin of -21.96%. Escalon Medical Corp.'s return on equity of -12.94% beat Axogen, Inc.'s return on equity of -13.75%.
Company Gross Margin Earnings Per Share Invested Capital ESMCEscalon Medical Corp.43.33% $0.01 $2.6M AXGNAxogen, Inc.74.13% -$0.28 $196.5M -
What do Analysts Say About ESMC or AXGN?
Escalon Medical Corp. has a consensus price target of --, signalling upside risk potential of 7641.94%. On the other hand Axogen, Inc. has an analysts' consensus of $40.56 which suggests that it could grow by 17.76%. Given that Escalon Medical Corp. has higher upside potential than Axogen, Inc., analysts believe Escalon Medical Corp. is more attractive than Axogen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ESMCEscalon Medical Corp.0 0 0 AXGNAxogen, Inc.7 0 0 -
Is ESMC or AXGN More Risky?
Escalon Medical Corp. has a beta of 0.181, which suggesting that the stock is 81.879% less volatile than S&P 500. In comparison Axogen, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 2.018%.
-
Which is a Better Dividend Stock ESMC or AXGN?
Escalon Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen, Inc. offers a yield of 0.17% to investors and pays a quarterly dividend of $0.00 per share. Escalon Medical Corp. pays -- of its earnings as a dividend. Axogen, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ESMC or AXGN?
Escalon Medical Corp. quarterly revenues are $3.6M, which are smaller than Axogen, Inc. quarterly revenues of $59.9M. Escalon Medical Corp.'s net income of $97.7K is higher than Axogen, Inc.'s net income of -$13.2M. Notably, Escalon Medical Corp.'s price-to-earnings ratio is 154.45x while Axogen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Escalon Medical Corp. is 0.15x versus 7.43x for Axogen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESMCEscalon Medical Corp.0.15x 154.45x $3.6M $97.7K AXGNAxogen, Inc.7.43x -- $59.9M -$13.2M
-
Which has Higher Returns ESMC or CNMD?
CONMED Corp. has a net margin of 2.72% compared to Escalon Medical Corp.'s net margin of 4.48%. Escalon Medical Corp.'s return on equity of -12.94% beat CONMED Corp.'s return on equity of 4.72%.
Company Gross Margin Earnings Per Share Invested Capital ESMCEscalon Medical Corp.43.33% $0.01 $2.6M CNMDCONMED Corp.57.12% $0.54 $1.9B -
What do Analysts Say About ESMC or CNMD?
Escalon Medical Corp. has a consensus price target of --, signalling upside risk potential of 7641.94%. On the other hand CONMED Corp. has an analysts' consensus of $44.20 which suggests that it could grow by 27.05%. Given that Escalon Medical Corp. has higher upside potential than CONMED Corp., analysts believe Escalon Medical Corp. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings ESMCEscalon Medical Corp.0 0 0 CNMDCONMED Corp.0 6 0 -
Is ESMC or CNMD More Risky?
Escalon Medical Corp. has a beta of 0.181, which suggesting that the stock is 81.879% less volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.986, suggesting its less volatile than the S&P 500 by 1.399%.
-
Which is a Better Dividend Stock ESMC or CNMD?
Escalon Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 2.35% to investors and pays a quarterly dividend of $0.20 per share. Escalon Medical Corp. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ESMC or CNMD?
Escalon Medical Corp. quarterly revenues are $3.6M, which are smaller than CONMED Corp. quarterly revenues of $373.5M. Escalon Medical Corp.'s net income of $97.7K is lower than CONMED Corp.'s net income of $16.7M. Notably, Escalon Medical Corp.'s price-to-earnings ratio is 154.45x while CONMED Corp.'s PE ratio is 22.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Escalon Medical Corp. is 0.15x versus 0.77x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESMCEscalon Medical Corp.0.15x 154.45x $3.6M $97.7K CNMDCONMED Corp.0.77x 22.48x $373.5M $16.7M
-
Which has Higher Returns ESMC or ELMD?
Electromed, Inc. has a net margin of 2.72% compared to Escalon Medical Corp.'s net margin of 14.61%. Escalon Medical Corp.'s return on equity of -12.94% beat Electromed, Inc.'s return on equity of 20.35%.
Company Gross Margin Earnings Per Share Invested Capital ESMCEscalon Medical Corp.43.33% $0.01 $2.6M ELMDElectromed, Inc.78.42% $0.32 $45.4M -
What do Analysts Say About ESMC or ELMD?
Escalon Medical Corp. has a consensus price target of --, signalling upside risk potential of 7641.94%. On the other hand Electromed, Inc. has an analysts' consensus of $37.00 which suggests that it could grow by 58.87%. Given that Escalon Medical Corp. has higher upside potential than Electromed, Inc., analysts believe Escalon Medical Corp. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ESMCEscalon Medical Corp.0 0 0 ELMDElectromed, Inc.3 0 0 -
Is ESMC or ELMD More Risky?
Escalon Medical Corp. has a beta of 0.181, which suggesting that the stock is 81.879% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.317, suggesting its less volatile than the S&P 500 by 68.266%.
-
Which is a Better Dividend Stock ESMC or ELMD?
Escalon Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Escalon Medical Corp. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ESMC or ELMD?
Escalon Medical Corp. quarterly revenues are $3.6M, which are smaller than Electromed, Inc. quarterly revenues of $18.9M. Escalon Medical Corp.'s net income of $97.7K is lower than Electromed, Inc.'s net income of $2.8M. Notably, Escalon Medical Corp.'s price-to-earnings ratio is 154.45x while Electromed, Inc.'s PE ratio is 22.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Escalon Medical Corp. is 0.15x versus 2.91x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESMCEscalon Medical Corp.0.15x 154.45x $3.6M $97.7K ELMDElectromed, Inc.2.91x 22.28x $18.9M $2.8M
-
Which has Higher Returns ESMC or GTHP?
Guided Therapeutics, Inc. has a net margin of 2.72% compared to Escalon Medical Corp.'s net margin of -1236.67%. Escalon Medical Corp.'s return on equity of -12.94% beat Guided Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ESMCEscalon Medical Corp.43.33% $0.01 $2.6M GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M -
What do Analysts Say About ESMC or GTHP?
Escalon Medical Corp. has a consensus price target of --, signalling upside risk potential of 7641.94%. On the other hand Guided Therapeutics, Inc. has an analysts' consensus of -- which suggests that it could grow by 46666566.67%. Given that Guided Therapeutics, Inc. has higher upside potential than Escalon Medical Corp., analysts believe Guided Therapeutics, Inc. is more attractive than Escalon Medical Corp..
Company Buy Ratings Hold Ratings Sell Ratings ESMCEscalon Medical Corp.0 0 0 GTHPGuided Therapeutics, Inc.0 0 0 -
Is ESMC or GTHP More Risky?
Escalon Medical Corp. has a beta of 0.181, which suggesting that the stock is 81.879% less volatile than S&P 500. In comparison Guided Therapeutics, Inc. has a beta of 0.747, suggesting its less volatile than the S&P 500 by 25.34%.
-
Which is a Better Dividend Stock ESMC or GTHP?
Escalon Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guided Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Escalon Medical Corp. pays -- of its earnings as a dividend. Guided Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ESMC or GTHP?
Escalon Medical Corp. quarterly revenues are $3.6M, which are larger than Guided Therapeutics, Inc. quarterly revenues of $60K. Escalon Medical Corp.'s net income of $97.7K is higher than Guided Therapeutics, Inc.'s net income of -$742K. Notably, Escalon Medical Corp.'s price-to-earnings ratio is 154.45x while Guided Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Escalon Medical Corp. is 0.15x versus 24.64x for Guided Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESMCEscalon Medical Corp.0.15x 154.45x $3.6M $97.7K GTHPGuided Therapeutics, Inc.24.64x -- $60K -$742K
-
Which has Higher Returns ESMC or IRIX?
IRIDEX Corp. has a net margin of 2.72% compared to Escalon Medical Corp.'s net margin of -1.25%. Escalon Medical Corp.'s return on equity of -12.94% beat IRIDEX Corp.'s return on equity of -119.2%.
Company Gross Margin Earnings Per Share Invested Capital ESMCEscalon Medical Corp.43.33% $0.01 $2.6M IRIXIRIDEX Corp.37.2% -$0.01 $9.5M -
What do Analysts Say About ESMC or IRIX?
Escalon Medical Corp. has a consensus price target of --, signalling upside risk potential of 7641.94%. On the other hand IRIDEX Corp. has an analysts' consensus of $2.75 which suggests that it could grow by 180.53%. Given that Escalon Medical Corp. has higher upside potential than IRIDEX Corp., analysts believe Escalon Medical Corp. is more attractive than IRIDEX Corp..
Company Buy Ratings Hold Ratings Sell Ratings ESMCEscalon Medical Corp.0 0 0 IRIXIRIDEX Corp.1 0 0 -
Is ESMC or IRIX More Risky?
Escalon Medical Corp. has a beta of 0.181, which suggesting that the stock is 81.879% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.753, suggesting its less volatile than the S&P 500 by 24.713%.
-
Which is a Better Dividend Stock ESMC or IRIX?
Escalon Medical Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Escalon Medical Corp. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ESMC or IRIX?
Escalon Medical Corp. quarterly revenues are $3.6M, which are smaller than IRIDEX Corp. quarterly revenues of $14.7M. Escalon Medical Corp.'s net income of $97.7K is higher than IRIDEX Corp.'s net income of -$184K. Notably, Escalon Medical Corp.'s price-to-earnings ratio is 154.45x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Escalon Medical Corp. is 0.15x versus 0.32x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESMCEscalon Medical Corp.0.15x 154.45x $3.6M $97.7K IRIXIRIDEX Corp.0.32x -- $14.7M -$184K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
